Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Biotech
Biotech
Page 2 of 19
Life
This company is launching a genetic matching feature for future parents—and the CEO says ‘it has nothing to do with eugenics’
By
Alexa Mikhail
March 23, 2025
Commentary
My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup
By
Michelle Werner
March 10, 2025
Leadership
A few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million
By
Lila MacLellan
March 1, 2025
Finance
Investors are plunking billions of dollars into AI-focused biopharma companies—a more than 300% increase from 2023
By
Healthcare Brew
and
Maia Anderson
January 31, 2025
Health
Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span
By
Beth Greenfield
January 24, 2025
Health
Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
By
Lindsey Leake
January 16, 2025
Tech
Merck snags Chinese obesity drug in nearly $2 billion deal
By
Robert Langreth
and
Bloomberg
December 19, 2024
Arnold Schwarzenegger is joining a Fortune 500 company to solve a great problem of his generation
By
Lindsey Leake
November 13, 2024
Leadership
23andMe’s entire board resigned on the same day. Founder Anne Wojcicki still thinks the startup is savable
By
Lila MacLellan
October 17, 2024
Will you live to 150? Here’s what 5 geneticists and aging researchers say
By
Alexa Mikhail
October 6, 2024
Health
How to delete your DNA data from 23andMe
By
Alexa Mikhail
October 5, 2024
Health
Free, at-home COVID tests are back. Here’s how to order yours
By
Lindsey Leake
September 24, 2024
Environment
California firm grows cocoa from cell cultures as climate change threatens supply
By
Amy Taxin
,
Terry Chea
and
The Associated Press
September 1, 2024
Health
Sergey Brin is using money from selling his Tesla shares to bankroll a startup developing hallucinogenic mental-health treatments
By
Marco Quiroz-Gutierrez
July 23, 2024
Newsletters
Exclusive: Holoclara raises $16 million Series A to develop therapeutics—with worms
By
Allie Garfinkle
June 27, 2024
Most Popular
Economy
The $38 trillion national debt is to blame for over $1 trillion in annual interest payments from here on out, CRFB says
By
Nick Lichtenberg
Success
As millions of Gen Zers face unemployment, McDonald's CEO dishes out some tough love career...
By
Preston Fore
AI
'Robots are going to be amongst us': Qualcomm exec says buckle up for the next 5 years. Your car is going to be the...
By
Nino Paoli